Viking Global Investors LP Roivant Sciences Ltd. Transaction History
Viking Global Investors LP
- $25.1 Billion
- Q2 2024
A detailed history of Viking Global Investors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Viking Global Investors LP holds 69,155,846 shares of ROIV stock, worth $794 Million. This represents 2.91% of its overall portfolio holdings.
Number of Shares
69,155,846
Previous 69,368,961
0.31%
Holding current value
$794 Million
Previous $731 Million
0.02%
% of portfolio
2.91%
Previous 2.78%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$819 Million6.97% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$766 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$406 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$337 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY23MShares$264 Million7.2% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.09B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...